MARKET

BMYMP

BMYMP

Bristol Myers
OTCPK
1,002.93
NaN%
Closed 09:30 02/20 EST
OPEN
--
PREV CLOSE
1,002.93
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1,053.37
52 WEEK LOW
724.11
MARKET CAP
3.58M
P/E (TTM)
289.91
1D
5D
1M
3M
1Y
5Y
1D
This Is A Stock Picker's Market
Seeking Alpha · 1d ago
Bristol-Myers Squibb: Oncology Franchise Remains A Core Strength
Seeking Alpha · 2d ago
Weekly Report: what happened at BMYMP last week (0209-0213)?
Weekly Report · 5d ago
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Seeking Alpha · 02/11 15:00
Weekly Report: what happened at BMYMP last week (0202-0206)?
Weekly Report · 02/09 09:41
Bristol-Myers Squibb outlines $46B–$47.5B 2026 revenue target as growth portfolio nears 60% of sales, driven by new product launches and pipeline catalysts
Seeking Alpha · 02/05 23:05
Weekly Report: what happened at BMYMP last week (0126-0130)?
Weekly Report · 02/02 09:40
Weekly Report: what happened at BMYMP last week (0119-0123)?
Weekly Report · 01/26 09:40
More
About BMYMP
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.

Webull offers Bristol-Myers Squibb Co stock information, including OTCPK: BMYMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMYMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMYMP stock methods without spending real money on the virtual paper trading platform.